Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21


Anti-OX40 Antibody Directly Enhances The Function of Tumor-Reactive CD8+ T Cells and Synergizes with PI3Kβ Inhibition in PTEN Loss Melanoma.

Peng W, Williams LJ, Xu C, Melendez B, McKenzie JA, Chen Y, Jackson HL, Voo KS, Mbofung RM, Leahey SE, Wang J, Lizee G, Tawbi HA, Davies MA, Hoos A, Smothers J, Srinivasan R, Paul EM, Yanamandra N, Hwu P.

Clin Cancer Res. 2019 Aug 1. doi: 10.1158/1078-0432.CCR-19-1259. [Epub ahead of print]


T(H)17 cells promote microbial killing and innate immune sensing of DNA via interleukin 26.

Meller S, Di Domizio J, Voo KS, Friedrich HC, Chamilos G, Ganguly D, Conrad C, Gregorio J, Le Roy D, Roger T, Ladbury JE, Homey B, Watowich S, Modlin RL, Kontoyiannis DP, Liu YJ, Arold ST, Gilliet M.

Nat Immunol. 2015 Sep;16(9):970-9. doi: 10.1038/ni.3211. Epub 2015 Jul 13.


Targeting of TLRs inhibits CD4+ regulatory T cell function and activates lymphocytes in human peripheral blood mononuclear cells.

Voo KS, Bover L, Harline ML, Weng J, Sugimoto N, Liu YJ.

J Immunol. 2014 Jul 15;193(2):627-34. doi: 10.4049/jimmunol.1203334. Epub 2014 Jun 13.


Selective targeting of Toll-like receptors and OX40 inhibit regulatory T-cell function in follicular lymphoma.

Voo KS, Foglietta M, Percivalle E, Chu F, Nattamai D, Harline M, Lee ST, Bover L, Lin HY, Baladandayuthapani V, Delgado D, Luong A, Davis RE, Kwak LW, Liu YJ, Neelapu SS.

Int J Cancer. 2014 Dec 15;135(12):2834-46. doi: 10.1002/ijc.28937. Epub 2014 May 12.


Antibodies targeting human OX40 expand effector T cells and block inducible and natural regulatory T cell function.

Voo KS, Bover L, Harline ML, Vien LT, Facchinetti V, Arima K, Kwak LW, Liu YJ.

J Immunol. 2013 Oct 1;191(7):3641-50. doi: 10.4049/jimmunol.1202752. Epub 2013 Sep 6.


HDAC11 plays an essential role in regulating OX40 ligand expression in Hodgkin lymphoma.

Buglio D, Khaskhely NM, Voo KS, Martinez-Valdez H, Liu YJ, Younes A.

Blood. 2011 Mar 10;117(10):2910-7. doi: 10.1182/blood-2010-08-303701. Epub 2011 Jan 14. Erratum in: Blood. 2014 Jul 17;124(3):464-5.


A novel subset of CD4(+) T(H)2 memory/effector cells that produce inflammatory IL-17 cytokine and promote the exacerbation of chronic allergic asthma.

Wang YH, Voo KS, Liu B, Chen CY, Uygungil B, Spoede W, Bernstein JA, Huston DP, Liu YJ.

J Exp Med. 2010 Oct 25;207(11):2479-91. doi: 10.1084/jem.20101376. Epub 2010 Oct 4.


Thymic stromal lymphopoietin-activated plasmacytoid dendritic cells induce the generation of FOXP3+ regulatory T cells in human thymus.

Hanabuchi S, Ito T, Park WR, Watanabe N, Shaw JL, Roman E, Arima K, Wang YH, Voo KS, Cao W, Liu YJ.

J Immunol. 2010 Mar 15;184(6):2999-3007. doi: 10.4049/jimmunol.0804106. Epub 2010 Feb 19.


Identification of IL-17-producing FOXP3+ regulatory T cells in humans.

Voo KS, Wang YH, Santori FR, Boggiano C, Wang YH, Arima K, Bover L, Hanabuchi S, Khalili J, Marinova E, Zheng B, Littman DR, Liu YJ.

Proc Natl Acad Sci U S A. 2009 Mar 24;106(12):4793-8. doi: 10.1073/pnas.0900408106. Epub 2009 Mar 9.


IL-25 augments type 2 immune responses by enhancing the expansion and functions of TSLP-DC-activated Th2 memory cells.

Wang YH, Angkasekwinai P, Lu N, Voo KS, Arima K, Hanabuchi S, Hippe A, Corrigan CJ, Dong C, Homey B, Yao Z, Ying S, Huston DP, Liu YJ.

J Exp Med. 2007 Aug 6;204(8):1837-47. Epub 2007 Jul 16.


CD4+ T-cell response to mitochondrial cytochrome B in human melanoma.

Voo KS, Zeng G, Mu JB, Zhou J, Su XZ, Wang RF.

Cancer Res. 2006 Jun 1;66(11):5919-26.


Toll-like receptor 8-mediated reversal of CD4+ regulatory T cell function.

Peng G, Guo Z, Kiniwa Y, Voo KS, Peng W, Fu T, Wang DY, Li Y, Wang HY, Wang RF.

Science. 2005 Aug 26;309(5739):1380-4.


Evidence for the presentation of major histocompatibility complex class I-restricted Epstein-Barr virus nuclear antigen 1 peptides to CD8+ T lymphocytes.

Voo KS, Fu T, Wang HY, Tellam J, Heslop HE, Brenner MK, Rooney CM, Wang RF.

J Exp Med. 2004 Feb 16;199(4):459-70. Epub 2004 Feb 9.


Identification of HLA-DP3-restricted peptides from EBNA1 recognized by CD4(+) T cells.

Voo KS, Fu T, Heslop HE, Brenner MK, Rooney CM, Wang RF.

Cancer Res. 2002 Dec 15;62(24):7195-9.


Identification and characterization of the DNA binding domain of CpG-binding protein.

Lee JH, Voo KS, Skalnik DG.

J Biol Chem. 2001 Nov 30;276(48):44669-76. Epub 2001 Sep 25.


Rapid resuspension of pelleted bacterial cells for miniprep plasmid DNA isolation.

Voo KS, Jacobsen BM.

Biotechniques. 1998 Feb;24(2):240-3. No abstract available.


Supplemental Content

Support Center